Aziyo Biologics to Report First Quarter 2022 Financial Results on Monday, May 9, 2022
Aziyo Biologics, Inc. (AZYO), a company in regenerative medicine, will report its Q1 2022 earnings after the market closes on May 9, 2022. The management will conduct a conference call at 4:30 PM ET on the same day to discuss financial performance. This call will also be available via webcast on the company’s website. Established in 2015, Aziyo focuses on innovative products for surgical patients, particularly those with implantable medical devices, and operates in cardiovascular, orthopedic, and reconstructive sectors.
- Company will release Q1 2022 earnings, indicating ongoing operations.
- Management will host a conference call to discuss financial performance, providing transparency to investors.
- None.
SILVER SPRING, Md., April 25, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced that it plans to release its first quarter 2022 earnings results after market close on Monday, May 9, 2022. Management will host a conference call to review the Company’s financial performance starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day. The conference call will be concurrently webcast.
The link to the webcast will be available on the Aziyo Biologics, Inc. website at www.aziyo.com under the investor relations section and will be archived for future reference. The call may be accessed through an operator by calling (833) 665-0667 for domestic callers and (914) 987-7319 for international callers using conference ID number 9975003.
About Aziyo Biologics
Aziyo Biologics is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. Since its founding in 2015, the Company has created a portfolio of commercial-stage products used in cardiovascular, orthopedic, and reconstructive specialties. For more information, visit www.Aziyo.com.
Media:
Courtney Guyer
Aziyo Biologics, Inc.
PR@aziyo.com
Investors:
Leigh Salvo
Gilmartin Group
investors@aziyo.com
FAQ
When will Aziyo Biologics release its Q1 2022 earnings results?
What time is the conference call for Aziyo Biologics Q1 2022 earnings?
How can I access the Aziyo Biologics earnings call?
Where can I find the webcast for Aziyo Biologics earnings call?
